Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

247.11
Delayed Data
As of 4:01pm ET
 +2.72 / +1.11%
Today’s Change
184.50
Today|||52-Week Range
261.27
+17.67%
Year-to-Date
The Long and Short of It
1:07pm / TheStreet.com - Paid Partner Content
FDA Commisoner Takes on Big Pharma
Jun 21 / TheStreet.com - Paid Partner Content
Getting Ever Smaller in Allergan
11:44am / TheStreet.com - Paid Partner Content
Time Frames and Market Views -- Selling Some Allergan
Jun 20 / TheStreet.com - Paid Partner Content
Putting More Allergan Profit in My Pocket
10:27am / TheStreet.com - Paid Partner Content
5 Reasons Why You Should Invest in AstraZeneca (AZN) in 2017
Jun 20 / Zacks.com - Paid Partner Content
Pocketing Some Allergan Profit
9:52am / TheStreet.com - Paid Partner Content
Still Lovin' Allergan
Jun 20 / TheStreet.com - Paid Partner Content
The Market Advance Narrows
7:14am / TheStreet.com - Paid Partner Content
Global pharma sales forecasts cut amid pricing pressures
Jun 20 / FT.com - Paid Partner Content

Today’s Trading

Previous close244.39
Today’s open244.39
Day’s range243.87 - 249.44
Volume2,723,034
Average volume (3 months)2,549,065
Market cap$82.1B
Dividend yield1.13%
Data as of 4:01pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+19.00%
Earnings growth (next 5 years)+13.70%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.04-0.09%
ABTAbbott Laboratories+0.70+1.44%
AZNAstraZeneca+0.48+1.38%
LLYEli Lilly and Co+1.67+2.02%
Data as of 4:02pm ET, 06/22/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$3.94
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts